Dylan Atkinson
About Dylan Atkinson
Dylan Atkinson is the Associate Director of Thoracic Oncology Marketing at Bristol Myers Squibb, with extensive experience in oncology marketing, healthcare policy, and pharmacy.
Title
Dylan Atkinson holds the title of Associate Director of Thoracic Oncology Marketing at Bristol Myers Squibb. He has held this position following a series of roles within the same company, showcasing his expertise and growth within the field of oncology marketing.
Professional Experience at Bristol Myers Squibb
Dylan Atkinson has an extensive work history with Bristol Myers Squibb. Prior to his current role as Associate Director of Thoracic Oncology Marketing, he served as Associate Director of Oncology Access Marketing from 2020 to 2022 and as Product Manager of Oncology Value Marketing from 2019 to 2020. He started at Bristol Myers Squibb as a US Value, Access & Payment Post-Doctoral Fellow from 2017 to 2019, marking the beginning of his impactful career at the company.
Past Roles and Internships
Dylan has accumulated a rich career trajectory through various roles and internships. He worked at Rutgers University as Adjunct Faculty, teaching from 2017 to 2019. Additionally, his earlier roles included stints as a Member Engagement Consultant at Pharmacy Quality Alliance, public policy intern positions at Idaho Board of Pharmacy and FDA, and several pharmacy intern positions across institutions such as UPMC Presbyterian Shadyside Hospital, Indian Health Service, and UPMC Health System.
Educational Background
Dylan Atkinson's educational accolades include a Doctor of Pharmacy (Pharm.D.) and a Bachelor’s Degree in Pharmaceutical Sciences from the University of Pittsburgh. He further pursued a Master of Public Health (MPH) in Health Systems and Policy from Rutgers University and completed foundational training in Marketing at The Tuck School of Business at Dartmouth.
Health Policy and Economics Expertise
Dylan has developed policy position letters on behalf of tens of thousands of individuals to help shape the healthcare landscape. He is experienced in managing multimillion-dollar budgets and modeling health economics for numerous stakeholders in the industry. His expertise extends to both public healthcare systems and private sector business decisions.